In this opinion piece, Phil Borgic, a hog farmer from Nokomis, Ill., and owner of Borgic Farms, Inc., urges FDA to stop standing in the way of biotechnology regulation.

Leaders of the three largest seed and chemical companies say it’s technologically possible to reduce farming’s environmental footprint while feeding a growing global population, but they worry policymakers and regulators will stand in the way. 

The CEO of seed and chemical giant Corteva Agriscience believes farmers must play a major role in reducing greenhouse gas emissions and says he's working with other companies as well as academics and non-governmental organizations to address the climate issue.

Crop developers say USDA’s effort to streamline its regulation of biotech crops will still slow the commercialization of many gene-edited products, but groups representing grain traders, food processors and restaurant chains are slamming the department's proposal, claiming it could lead to trade disruptions and undermine consumer confidence. 

Last week, the Food and Drug Administration (FDA) responded to calls from our community to reconsider its role in regulating gene editing technology in animal agriculture. Despite the Trump administration’s recent directive to streamline costly and overly burdensome regulations that inhibit innovation and investment, FDA maintains it is unwilling to cede any regulatory control of this important technology.

Many new genetically engineered crop traits would be exempt from regulation by the Agriculture Department under a sweeping rewrite of its rules for testing and assessing the products.